Moderna Inc said on Monday its COVID-19 vaccine generated a strong immune response and was generally well-tolerated in children aged six to 11 years, citing interim data from a study.
The company said it planned to submit the data to U.S., European and other regulators soon.
Moderna said the data showed two 50 microgram doses of the vaccine, half the strength of the doses used in the vaccine given to adults, generated virus-neutralizing antibodies in children.
The majority of side effects were mild or moderate in severity, the company said. The most common solicited adverse events were fatigue, headache, fever and injection site pain.
Britain's military bases experienced a doubling of drone incidents last year, highlighting the changing nature of warfare and prompting the government to hand more powers to its forces t...
Israel reopened the border between Gaza and Egypt on Monday for a limited number of people on foot, allowing a small number of Palestinians to leave the enclave and some of those who esc...
Updated 1300
Momentum warns against compensating illegal outdoor structures after Storm Harry: Momentum has urged authorities to exclude illegally placed outdoor furniture from eligib...
US Ambassador to Malta mentioned in Epstein's files
Somers Farkas, who became the US ambassador to Malta two months ago and is known for supporting Donald Trump, was referenced in a 2...
Updated 1300
The European Parliament dedicated a special plenary session marking the International Holocaust Remembrance Day and the liberation of the Auschwitz-Birkenau concentration...
The European Parliament and the Council have reached an informal agreement on new EU rules aimed at strengthening protections for retail investors, improving access to quality financial ...
Italy’s unemployment rate fell to 5.6% in December, marking the lowest level recorded since the start of comparable data in 2004, according to provisional figures released by the nationa...
Gold and silver prices have continued to fall after a dramatic reversal of a rally that had pushed precious metals to record highs.
In Asia trade on Monday, spot gold prices fell more...
Vivian continues to widen its portfolio with the announcement of new representation agreements with worldwide R&D pharmaceutical companies. “These latest agreements crown a very succ...
Two local analysts have cautioned that any attempt by EU Member States to block or restrict the passporting of crypto-asset service providers (CASPs) authorised under the Markets in...
Employers are increasingly realising the benefits of incorporating environmental, social and governance (ESG) considerations into their business strategies as opposed to treating ESG as ...
Vivian has entered into a distribution agreement with worldwide R&D pharmaceutical company Novartis Pharma Services AG, a move that continues to reflect Vivian’s established reputati...
A significant explosion struck the southern Iranian port city of Bandar Abbas earlier today, sending shockwaves through the region. The initial blast occurred in an eight-storey building...
U.S. President Donald Trump urged Iran to come to the table and make a deal on nuclear weapons or the next U.S. attack would be far worse. Tehran responded with a threat to strike back a...
Venezuela transported gold worth almost 4.14 billion Swiss francs ($5.20 billion) to Switzerland during the early years of the leadership of ousted President Nicolas Maduro, customs data...
More than a dozen journalists were detained on Monday while covering political events in Venezuela’s capital Caracas, including a pro-government march and the swearing-in of a new legisl...
The attacks hitting a miners' bus in Pavlohrad in the Dnipropetrovsk region, and a maternity hospital in Zaporizhzhia, come as Ukraine's president announced trilateral peace talks in the...
Ukrainian president Volodymyr Zelenskyy has said he wanted to target 2027 for Ukraine’s accession to the European Union.
In a brief update after his phone call with Austrian chancello...
